Tadamichi Akagi, Alcon (R), Bayer (R), Canon (R), Kowa (R), Pfizer (R), Santen (R), Senju (R);
Akihito Uji, Alcon (R), Canon (R), Santen (R), Senju (R);
Yoko Okamoto, None;
Kenji Suda, Alcon (F), Kowa (R), Otsuka (R), Santen (R), Senju (R);
Takanori Kameda, Alcon (R), Kowa (R), Pfizer (R), Santen (R), Senju (R), Tomey (F), Tomey (R);
Hideo Nakanishi, Alcon (R), HOYA (R), Novartis (F), Pfizer (R), Santen (R), Tomey (F), Tomey (R);
Hanako Ikeda, Alcon (F), Alcon (R), Kyoto Drug Descovery & Development (F), Novartis (F), Santen (R), Senju (R), Wakamoto (R);
Masahiro Miyake, Alcon (R), HOYA (R), Japan Medical Instruments Association (R), Kowa (R), Santen (R);
Eri Nakano, None;
Naohiro Motozawa, None;
Akitaka Tsujikawa, Alcon (F), AMO Japan (F), Atsuzawa (F), Bayer (F), Bayer (R), Canon (F), Daiichi Sankyo (R), HOYA (F), Janssen Pharma (R), Japan Medical Instruments Association (F), JFC (F), Johnson & Johnson (R), Kowa (F), Kyoto Drug Discovery & Development (R), Novartis (F), Novartis (R), Pfizer (F), Pfizer (R), Santen (F), Santen (R), Senju (F), Senju (R), Tomey (F), Wakamoto (F), Wakamoto (R)